FLT3D835Y/F691L-IN-1
Selected Variant
T209898-01
Size: 10 mg
Product Specifications
Target
FLT
Related Pathways
Tyrosine Kinase/Adaptors, Angiogenesis
Bioactivity
FLT3D835Y/F691L-IN-1 (compd 8v) is an orally active inhibitor targeting the secondary mutations D835Y/F691L in the FLT3 tyrosine kinase domain, with IC50 values of 1.5 and 9.7 nM, respectively. This compound is applicable in research related to acute myeloid leukemia.
Molecular Formula
C26H37N7O4
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Price
Sign In for Pricing
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC881099-100 1x 100 µL
CD31 / PECAM-1 (C31.3 + C31.7 + C31.10), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC882058-500 1x 500 µL
HPV-16 (Human Papilloma Virus 16) (HPV16/2058R), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC881218-500 1x 500 µL
CELA3B (CELA3B/1218), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
M02103-2 100 µL/Vial
Anti-Angiotensinogen Rabbit Monoclonal Antibody
Sign In for Pricing
View Details 
PB9734-carrier-free 100 µg/Vial
Anti-Pax2 Antibody Picoband® (Carrier-free Conjugate)
Sign In for Pricing
View Details